PharmaCyte Biotech, Inc. (PMCB)
NCM · Common · CUSIP 71715X203
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PMCB and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
71715X203 (prev. 717512X20 )
Market Cap
Micro Cap
Business: PharmaCyte Biotech, Inc. is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology is being used as a platform upon which therapies for several types of cancer and diabetes are being developed.

Company Contact

CEO
Joshua N. Silverman
CFO
Carlos A. Trujillo
Headquarters
23046 Avenida de la Carlota, Suite 600, Laguna Hills, CA 92653
Phone
917-592-2850
Investor Relations
Gerald W. Crabtree · 917-595-2856 · ir@pharmacyte.com
SEC EDGAR Filings
View filings »